East Asia & Pacific (IDA & IBRD countries) | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
East Asia & Pacific (IDA & IBRD countries)
Records
63
Source
East Asia & Pacific (IDA & IBRD countries) | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
0.0528842 1980
0.07602237 1981
0.57539773 1982
54.63097724 1983
60.71263364 1984
66.35093693 1985
55.44657594 1986
67.43856763 1987
82.84315759 1988
85.12820246 1989
89.37872043 1990
85.80552056 1991
82.34509553 1992
78.47617615 1993
75.20261094 1994
78.10395555 1995
83.22992265 1996
82.59628068 1997
82.88550489 1998
83.39546664 1999
82.88566714 2000
83.31317175 2001
82.73660195 2002
83.51918764 2003
85.44083414 2004
85.50456666 2005
89.66438868 2006
89.24828265 2007
91.55317003 2008
92.8526681 2009
93.51166505 2010
93.69069683 2011
93.71683856 2012
94.71966383 2013
94.42166349 2014
94.3256081 2015
94.68298134 2016
94.48058369 2017
94.58868445 2018
93.62424415 2019
91.22654256 2020
86.19898732 2021
90.03600315 2022
East Asia & Pacific (IDA & IBRD countries) | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
East Asia & Pacific (IDA & IBRD countries)
Records
63
Source